The applicability of the assay was demonstrated using skeletal muscle biopsies from patients with LGMD2I/R9, a disease caused by mutations in fukutin-related protein gene (FKRP). This evidence concerns the gene FKRP and autosomal recessive limb-girdle muscular dystrophy type 2I.